<DOC>
	<DOC>NCT00198458</DOC>
	<brief_summary>The objective of this study was to rule out a greater than 10% incidence of hypersensitivity to Vitrase following a single intradermal injection of 3 USP units Vitrase. Less than or equal to a 10% hypersensitivity response was considered acceptable.</brief_summary>
	<brief_title>Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<criteria>Agreed to avoid disallowed meds Known hypersensitivity to hyaluronidase and/or bee sting Previous known exposure to ovine hyaluronidase or bovine hyaluronidase Atopic individuals assessed by medical history Topical/inhaled/systemic corticosteroids within 30 days Concurrent use of antihistamines or antiinflammatory during study Active or chronic disease likely to affect immune function History of alcohol/drug abuse within 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>